Rituximab Treatment in Sjogren's Syndrome

• Status: Completed
• Trial end date: 2008-10-01

Summary

This study is an evaluation of the effect of rituximab compared to placebo in combination with steroids on salivary flow and serological and clinical parameters in patients with primary SS.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: University Medical Center Groningen
• Collaborator: Hoffmann-La Roche
• Treatments: Rituximab